Donate

Audio Archive

Episodes by Date

Calendar is loading...
Loading...

Be a Part of Forum

KQED BOOKS

Girl reading on a train platform. Credit: Mo Riza/Flickr

All of KQED's book coverage and author interviews in one place.

Follow us on Twitter

Twitter bird in blue

Stay updated on show topics, relevant articles, and easily submit your questions.

BOOKS THAT MATTER


KQED Books wants to know what book left its mark on you.

KQED e-Newsletters

Newsletters

Get regular updates on great programs and events

Please leave this field empty

More from KQED

Forum

Mon, Jun 4, 2012 -- 10:00 AM

Preventing Alzheimer's


Download audio (MP3)

Sebastien Bozon/AFP/Getty Images
A woman, suffering from Alzheimer's desease, walks in a corridor on March 18, 2011 in a retirement home.
Sebastien Bozon/AFP/Getty Images
A woman, suffering from Alzheimer's desease, walks in a corridor on March 18, 2011 in a retirement home.

A new trial of an Alzheimer's drug will test whether it can prevent the onset of the disease in people who are genetically predisposed to get it. If the drug is successful, there is hope -- but no guarantee -- that it could prevent Alzheimer's among the general public. We discuss the trial and its possible implications.

Host: Dave Iverson

Guests:

  • Eric Reiman, CEO of Banner Research and executive director of Banner Alzheimer's Institute, a nonprofit dedicated to preventing Alzheimer's that is one of the study's leaders
  • Geoffrey Kerchner, assistant professor of neurology at the Stanford School of Medicine
  • William Fisher, CEO of the Alzheimer's Association of Northern California and Northern Nevada

Sponsored by

Sponsored by